Tepezza Hearing Loss

In litigation Mass-tort payouts ($50k+) mass_tort · pharma

Tepezza hearing loss - MDL alleges the thyroid-eye-disease drug causes permanent hearing damage

Eligibility hint

Were treated with Tepezza infusions and developed hearing loss or tinnitus

Estimated payout range

$50,000 – $1,000,000

Current score

0.60 / 1.00

Official source

View source →

Tepezza (teprotumumab), a Horizon Therapeutics infusion drug for thyroid eye disease, is alleged to cause permanent hearing loss and tinnitus that the label failed to adequately warn about. The federal cases are consolidated in an MDL in the Northern District of Illinois. Eligibility centers on having been treated with Tepezza infusions and later developing hearing loss or tinnitus.

Recent signals

Dexcom G7 CGM Covered by Medicare; T1D Off-Label Drug Use; Another Tepezza Lawsuit - medpagetoday.com google_news · 2026-10-06
CL filing: IN RE: DUPIXENT (DUPILUMAB) PRODUCTS LIABILITY LITIGATION courtlistener_search · 2026-09-30
Amgen's $28B Horizon buyout cleared for takeoff after FTC, states settle - Fierce Pharma google_news · 2026-09-04
FTC Agreement Clears Amgen to Proceed with $27.8B Horizon Deal - BioSpace google_news · 2026-09-03
FTC allows Amgen’s $28B deal for Horizon to go through, with conditions - BioPharma Dive google_news · 2026-09-03
Horizon releases additional Tepezza phase 4 data for TED - Glance by Eyes On Eyecare google_news · 2026-09-03
CL filing: In Re Instructure Data Breach Litigation courtlistener_search · 2026-08-15
CL filing: IN RE: Apple Airtag Marketing, Sales Practices, and Products Liability Litigation courtlistener_search · 2026-08-11
FAERS: tepezza - Retinal detachment, Fatigue, Off label use, Decreased appetite, Taste disorder fda_faers · 2026-08-04
FAERS: tepezza - Breast cancer fda_faers · 2026-08-04

Brands: horizon therapeuticsamgen
Products: tepezzateprotumumabthyroid eye diseasehearing losstinnitus

Frequently asked questions

Who qualifies for the Tepezza Hearing Loss case?

You may qualify if the following applies to you: Were treated with Tepezza infusions and developed hearing loss or tinnitus. Eligibility criteria can change as the case develops.

How much could a Tepezza Hearing Loss claim be worth?

Estimated payouts range from $50,000 to $1,000,000 depending on individual circumstances. These are estimates based on comparable outcomes, not guarantees.

What is the current status of the Tepezza Hearing Loss case?

In litigation. Tepezza (teprotumumab), a Horizon Therapeutics infusion drug for thyroid eye disease, is alleged to cause permanent hearing loss and tinnitus that the label failed to adequately warn about. The federal cases are consolidated in an MDL in the Northern District of Illinois. Eligibility centers on having been treated with Tepezza infusions and later developing hearing loss or tinnitus.

How do I check whether I'm included?

Take the free 30-second audit at https://getclaimscout.com/audit and claimscout matches the brands and products you've used against every active class action settlements and mass torts it tracks, or review the eligibility details at https://getclaimscout.com/matters/tepezza-hearing-loss.

Think this might apply to you?
Take a 30-second audit and we'll match every brand you've used against active settlements.

Start audit →

On iPhone? Get the Claimscout app and follow this settlement for updates.

Building an AI agent? This matter is available as JSON at https://getclaimscout.com/api/v1/matters/tepezza-hearing-loss, and the full registry is at /api/v1/matters. Agent quickstart: /llms.txt. Schema: /openapi.json.